<DOC>
	<DOCNO>NCT00078000</DOCNO>
	<brief_summary>Assessment safety efficacy SU11248 patient metastatic breast cancer fail select therapy .</brief_summary>
	<brief_title>A Study SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies .</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Anthracycline taxanerefractory intolerant metastatic breast cancer Female Prior treatment 3 great regimen chemotherapy advanced/metastatic disease set beyond contain anthracyclines/taxanes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>